Respiratory – September 2020 Respiratory – September 2020 FDA Accepts Application for Xolair (omalizumab) prefilled syringe for self-administration across all indications 12 Aug 2020 Xolair (Omalizumab, Anti-IgE mAb) – Genentech/Novartis The application acceptance is based on the well-established efficacy and […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id